Stay updated on BI 836858 & Decitabine Combo in AML Clinical Trial
Sign up to get notified when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.

Latest updates to the BI 836858 & Decitabine Combo in AML Clinical Trial page
- Check3 days agoChange DetectedRevision history updated: Revision v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations section structure updated: added a general Locations section and state entries for Florida, Illinois, New York, and Ohio; removed Florida Locations, Illinois Locations, New York Locations, and Ohio Locations. Revision updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check53 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 with no change to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedFunding-status notice banner removed from the page, eliminating information about potential delays and limited site responses.SummaryDifference0.3%

- Check74 days agoChange DetectedThe page shows minor layout and formatting updates to the study record without altering core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check103 days agoChange DetectedAdditions introduce an operational status notice and new version v3.2.0; deletions remove the prior v3.1.0 tag. The most significant change is the updated operational status messaging and the version bump.SummaryDifference4%

Stay in the know with updates to BI 836858 & Decitabine Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.